Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czechia
Cyprus
Denmark
Estonia
Germany
Hungary
Italy
Kosowo
Latvia
Lithuania
Luxembourg
Macedonia
Montenegro
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
Hong Kong
Kuwait
Lebanon
UAE
RSA
Subsidiaries of Vita 34 reach agreement with US licensor
— End of inside information pursuant to Art. 17 MAR —End of Inside InformationInformation and Explanation
Read more
Investor News
Go to section:
-
-
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Vita 34 AG / Key word(s): Annual Results/ForecastVita 34 closes 2023 with significantly better results Read more
-
Vita 34 publishes preliminary figures on the course of business in 2023 — End of inside information pursuant to Art. 17 MAR —End of Inside InformationInformation and Explanation Read more
-
Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors Vita 34 AG / Key word(s): Capital IncreaseVita 34 AG: resolves on cash capital increase under exclusion Read more
-
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements — End of inside information according to Art. 17 MAR —End of Inside InformationInformation and Explanation Read more
-
Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor Vita 34 AG / Key word(s): Legal MatterVita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit Read more
Registration for our Email Service
You can register to be on the distribution list for our IR news with the following contact form in order to receive our latest publications and other notifications.